• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BAL

BELLAMY'S AUSTRALIA LIMITED

0.16% ! $19.10
Currently unlisted.
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BAL
bal target $30
2
24/04/18 111 43K
24/04/18 Last post  asb83 Comments Created with Sketch.  111  Views Created with Sketch.  43K 
BAL
A market in India for BAL? 		23/04/18 0 187
23/04/18 Last post  PhantomGWW Comments Created with Sketch.  0  Views Created with Sketch.  187 
BAL
Ann: Change in substantial holding 		23/04/18 9 3.4K
23/04/18 Last post  Jukebox45 Comments Created with Sketch.  9  Views Created with Sketch.  3.4K 
BAL
Ann: Appendix 3B 		23/04/18 0 273
23/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  273 
BAL
Ann: Guidance Update & Conditional Acquisition of Camperdown 		22/04/18 9 5.2K
22/04/18 Last post  rvajna Comments Created with Sketch.  9  Views Created with Sketch.  5.2K 
BAL
Competition woes 		18/04/18 0 428
18/04/18 Last post  Misspelly Comments Created with Sketch.  0  Views Created with Sketch.  428 
BAL
CFDA 		17/04/18 37 14K
17/04/18 Last post  GoMaRket Comments Created with Sketch.  37  Views Created with Sketch.  14K 
BAL
Dividend coming? 		13/04/18 2 1.1K
13/04/18 Last post  lakota6 Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 

See All Discussions arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

AFT Pharmaceutical's multi-billion R&D opportunity

Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut SpaceX has revisited its $135 listing price after an explosive IPO as investors reassess lofty valuations ahead of its first earnings report.
Prairie Lithium advances towards first production as commercial DLE unit arrives Prairie Lithium (ASX:PL9) has reached a major milestone in its path to first production, with North America’s largest commercial Direct Lithium Extraction (DLE) unit now delivered to site in Saskatchewan. The arrival marks the start of installation as the ASX-listed company moves ...
Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms Askari Metals has spent months laying the groundwork in Ethiopia. Now, the explorer is approaching a new story about the drill core.
Klevo Rewards advances stablecoin strategy with credit licence acquisition Klevo Rewards CEO Alexander Gold talks to HotCopper about officially completing the acquisition of an Australian credit licence.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.